Scarica l'app Stockscreener
20.14
37.04%
-11.85
Dopo l'orario di chiusura:
20.35
0.21
+1.04%
Precedente Chiudi:
$31.99
Aprire:
$22.75
Volume 24 ore:
8.13M
Relative Volume:
9.63
Capitalizzazione di mercato:
$886.66M
Reddito:
$78.02M
Utile/perdita netta:
$-73.37M
Rapporto P/E:
-15.26
EPS:
-1.32
Flusso di cassa netto:
$-62.06M
1 W Prestazione:
-31.15%
1M Prestazione:
-30.58%
6M Prestazione:
+51.66%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$20.02
$23.92
Intervallo di 1 settimana:
$20.02
$32.58
Portata 52W:
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Nome
Beta Bionics Inc
Settore
Industria
Telefono
949-427-7785
Indirizzo
11 HUGHES, IRVINE
Confronta BBNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
20.14 | 1.41B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-10-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-06-12 | Iniziato | Lake Street | Buy |
| 2025-05-30 | Iniziato | Goldman | Neutral |
| 2025-05-30 | Iniziato | Wolfe Research | Outperform |
| 2025-02-24 | Iniziato | BofA Securities | Buy |
| 2025-02-24 | Iniziato | Lake Street | Buy |
| 2025-02-24 | Iniziato | Leerink Partners | Outperform |
| 2025-02-24 | Iniziato | Piper Sandler | Overweight |
| 2025-02-24 | Iniziato | Stifel | Buy |
| 2025-02-20 | Iniziato | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Iniziato | Robert W. Baird | Neutral |
Mostra tutto
Beta Bionics Inc Borsa (BBNX) Ultime notizie
Beta Bionics Shares Fall After BofA Securities Downgrade - MarketScreener
Beta Bionics Tumbles 32% on Analyst Downgrade - Orange County Business Journal
Beta Bionics stock tumbles following deceleration in new patient starts By Investing.com - Investing.com India
Beta Bionics stock tumbles following deceleration in new patient starts - Investing.com
BofA Securities Downgrades Beta Bionics to Neutral From Buy, Adjusts Price Target to $28 From $33 - MarketScreener
Premium Valuation and Slowing New Patient Growth Drive Shift to Neutral on Beta Bionics - TipRanks
Beta Bionics stock to exceed Q4 revenue targets, Stifel maintains Buy - Investing.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
How Beta Bionics Inc. stock reacts to inflationary pressuresJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - ulpravda.ru
BofA Securities downgrades Beta Bionics stock to Neutral on valuation concerns - Investing.com Australia
Is Beta Bionics Inc. stock a safe buy before earningsGap Up & Trade Opportunity Analysis Reports - ulpravda.ru
Will Beta Bionics Inc. stock attract more institutional investorsWeekly Profit Report & Free Reliable Trade Execution Plans - ulpravda.ru
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics - GlobeNewswire
How Beta Bionics Inc. stock performs in weak economyWeekly Trade Report & AI Based Buy and Sell Signals - ulpravda.ru
Is Beta Bionics Inc. stock positioned for digital transformation2025 AllTime Highs & Accurate Buy Signal Notifications - ulpravda.ru
Will Beta Bionics Inc. stock keep outperforming rivalsJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Insider Sell: Mike Mensinger Sells 2,200 Shares of Beta Bionics Inc (BBNX) - GuruFocus
Insider Sell: Mike Mensinger Sells 7,800 Shares of Beta Bionics Inc (BBNX) - GuruFocus
Mike Mensinger Sells 7,800 Shares of Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
Insider Selling: Beta Bionics (NASDAQ:BBNX) CFO Sells 20,000 Shares of Stock - MarketBeat
Beta Bionics CFO Sells 20,000 Shares - TradingView — Track All Markets
Bank of America Forecasts Strong Price Appreciation for Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
FOMO Trade: How Beta Bionics Inc stock reacts to inflationary pressuresWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Aug Weekly: Why analysts upgrade Beta Bionics Inc stockLayoff News & Community Supported Trade Ideas - moha.gov.vn
Beta Bionics Reports Strong Q3 Growth Amid Challenges - MSN
Fourteen new option listings on November 12th - MSN
Beta Bionics, Inc. (BBNX) Stock Analysis: A Promising Growth Story with 63.10% Revenue Surge - DirectorsTalk Interviews
Artificial Pancreas System Market is set for steady growth to US$ - openPR.com
Beta Bionics (NASDAQ:BBNX) Trading Up 8.7%Should You Buy? - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Review: How Beta Bionics Inc. stock performs during Fed tightening cyclesJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда
Why Beta Bionics Inc. stock is a must watch in 20252025 Price Action Summary & Low Risk High Win Rate Picks - Улправда
Why Beta Bionics Inc. stock is a value investor pickDollar Strength & Advanced Technical Analysis Signals - ulpravda.ru
Why Beta Bionics Inc. stock is rated strong buyMarket Growth Summary & Intraday High Probability Setup Alerts - DonanımHaber
How Beta Bionics Inc. stock performs during Fed tightening cyclesJuly 2025 Volume & Safe Capital Growth Stock Tips - Улправда
Truist Securities Maintains Beta Bionics (BBNX) Buy Recommendation - Nasdaq
Is Beta Bionics (BBNX) Overvalued After Its Recent Share Price Momentum? - Yahoo Finance
Beta Bionics (NASDAQ:BBNX) Sees Strong Trading Volume Following Analyst Upgrade - MarketBeat
Truist Securities Adjusts Price Target on Beta Bionics to $37 From $32, Maintains Buy Rating - marketscreener.com
Beta Bionics (NASDAQ:BBNX) Given New $37.00 Price Target at Truist Financial - MarketBeat
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas - MSN
Beta Bionics Earnings Notes - Trefis
Beta Bionics stock rating reiterated at Buy by Stifel - Investing.com Australia
Beta Bionics: It Has Been An Interesting Year (NASDAQ:BBNX) - Seeking Alpha
Beta Bionics, Inc. $BBNX Shares Purchased by Walleye Capital LLC - MarketBeat
BBNX FinancialsIncome Statement - Quiver Quantitative
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - The Manila Times
Divisadero Street Capital Management LP Purchases New Shares in Beta Bionics, Inc. $BBNX - MarketBeat
This Beta Bionics Insider Increased Their Holding By 130% Last Year - simplywall.st
Insider Selling: Beta Bionics (NASDAQ:BBNX) CFO Sells 1,427 Shares of Stock - MarketBeat
Feider Stephen (Beta Bionics) sells $41,862 in shares By Investing.com - Investing.com Canada
Beta Bionics Inc Azioni (BBNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.31%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):